[Treatment of Vitiligo]

Overview

Journal Hautarzt

Specialty Dermatology

Date 2016 Feb 25

PMID 26909811

Citations 2

Authors

M Meurer

M Schild

Affiliations

Soon will be listed here.

Abstract

The range of treatment options for vitiligo has significantly expanded in the last 10 years and we can offer our patients more effective treatment strategies supported by European guidelines and consensus findings. Topical and UV therapy are-often in combination-the main components of vitiligo treatment. The main outcome parameters include extent and maintenance of gained repigmentation, cessation of spreading, avoidance of side effects and the influence of the treatment on the quality of life. The efficacy of the currently available treatments is often limited. New options include antioxidative or melanocyte-stimulating adjuvant therapies in combination with UV or laser light as well as a topical maintenance treatment to reduce the risk of recurrences. In many cases, psychological support is indicated.

Citing Articles

[Systemic treatment of vitiligo : Balance and current developments].

Meurer M, Ceric-Dehdari P Hautarzt. 2017; 68(11):876-884.

PMID: 29030646 DOI: 10.1007/s00105-017-4065-6.

Epidermal skin grafting in vitiligo: a pilot study.

Janowska A, Dini V, Panduri S, Macchia M, Oranges T, Romanelli M Int Wound J. 2016; 13 Suppl 3:47-51.

PMID: 27547963 PMC: 7950019. DOI: 10.1111/iwj.12632.

References

Lilly E, Lu P, Borovicka J, Victorson D, Kwasny M, West D . Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2012; 69(1):e11-8. DOI: 10.1016/j.jaad.2012.01.038. View

Taieb A, Picardo M . The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007; 20(1):27-35. DOI: 10.1111/j.1600-0749.2006.00355.x. View

Kumaran M, Kaur I, Kumar B . Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol. 2006; 20(3):269-73. DOI: 10.1111/j.1468-3083.2006.01420.x. View

Rigopoulos D, Gregoriou S, Larios G, Moustou E, Belayeva-Karatza E, Kalogeromitros D . Etanercept in the treatment of vitiligo. Dermatology. 2007; 215(1):84-5. DOI: 10.1159/000102044. View

Taieb A, Alomar A, Bohm M, Dellanna M, De Pase A, Eleftheriadou V . Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 2012; 168(1):5-19. DOI: 10.1111/j.1365-2133.2012.11197.x. View

Grimes P, Hamzavi I, Lebwohl M, Ortonne J, Lim H . The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol. 2013; 149(1):68-73. DOI: 10.1001/2013.jamadermatol.386. View

Smith D, Tofte S, Hanifin J . Repigmentation of vitiligo with topical tacrolimus. Dermatology. 2002; 205(3):301-3. DOI: 10.1159/000065845. View

Meurer M, Folster-Holst R, Wozel G, Weidinger G, Junger M, Brautigam M . Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology. 2002; 205(3):271-7. DOI: 10.1159/000065863. View

Falabella R . Vitiligo and the melanocyte reservoir. Indian J Dermatol. 2010; 54(4):313-8. PMC: 2807704. DOI: 10.4103/0019-5154.57604. View

10.

Gibbons N, Wood J, Rokos H, Schallreuter K . Computer simulation of native epidermal enzyme structures in the presence and absence of hydrogen peroxide (H2O2): potential and pitfalls. J Invest Dermatol. 2006; 126(12):2576-82. DOI: 10.1038/sj.jid.5700612. View

11.

Jamal S, Schneider R . UV-induction of keratinocyte endothelin-1 downregulates E-cadherin in melanocytes and melanoma cells. J Clin Invest. 2002; 110(4):443-52. PMC: 150409. DOI: 10.1172/JCI13729. View

12.

Whitton M, Ashcroft D, Barrett C, Gonzalez U . Interventions for vitiligo. Cochrane Database Syst Rev. 2006; (1):CD003263. DOI: 10.1002/14651858.CD003263.pub3. View

13.

Mulekar S, Isedeh P . Surgical interventions for vitiligo: an evidence-based review. Br J Dermatol. 2013; 169 Suppl 3:57-66. DOI: 10.1111/bjd.12532. View

14.

Boone B, Ongenae K, van Geel N, Vernijns S, De Keyser S, Naeyaert J . Topical pimecrolimus in the treatment of vitiligo. Eur J Dermatol. 2007; 17(1):55-61. DOI: 10.1684/ejd.2007.0093. View

15.

Korobko I . Review of current clinical studies of vitiligo treatments. Dermatol Ther. 2012; 25 Suppl 1:S17-27. DOI: 10.1111/dth.12008. View

16.

Dellanna M, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin A . Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol. 2007; 32(6):631-6. DOI: 10.1111/j.1365-2230.2007.02514.x. View

17.

Schild M, Meurer M . [Vitiligo: Clinical presentation and pathogenesis]. Hautarzt. 2016; 67(2):173-86. DOI: 10.1007/s00105-015-3751-5. View

18.

Olsson M, Juhlin L . Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension. Br J Dermatol. 2002; 147(5):893-904. DOI: 10.1046/j.1365-2133.2002.04837.x. View

19.

Radmanesh M, Saedi K . The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients. J Dermatolog Treat. 2006; 17(3):151-3. DOI: 10.1080/09546630600791442. View

20.

Babu A, Thappa D, Jaisankar T . Punch grafting versus suction blister epidermal grafting in the treatment of stable lip vitiligo. Dermatol Surg. 2007; 34(2):166-78. DOI: 10.1111/j.1524-4725.2007.34034.x. View